Clinical Trial

Effect of Pulsatile Hormone Administration on Insulin Action

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 16, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
In humans, insulin is secreted in pulses from the pancreatic beta-cells, and these oscillations help to maintain fasting plasma glucose levels within a narrow normal range. Given the fluctuations in insulin concentrations, oscillations enhance precision of control. The hyperinsulinemic euglycemic clamp test (clamp) involves a continuous infusion of insulin and is the gold standard for measuring insulin sensitivity. In this study, insulin sensitivity measured using the standard clamp will be compared with a clamp in which the same total amount of insulin as the standard clamp is infused every five minutes instead of continuously.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-01-11; most recent amendment 2025-01-14.
Status change: Not Yet Recruiting → Recruiting 2024-01-26
Trial Details
NCT Number NCT06216665
Lead Sponsor Pennington Biomedical Research Center
Conditions Insulin Sensitivity
Enrollment 12 participants
Start Date 2024-03-04
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-01-16